Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Tax Withholding |
2025-04-03 4:38 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
26,571 | $5.095 | 2,116,561 (Direct) |
View |
| 2025-03-17 Tax Withholding |
2025-03-19 4:27 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
7,057 | $6.84 | 2,143,132 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-20 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
10,879 | $10.64 | 2,150,189 (Direct) |
View |
| 2025-02-03 Tax Withholding |
2025-02-05 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
6,544 | $7.25 | 2,161,068 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:50 pm |
N/A 2035-02-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
118,977 | $0 | 2,161,068 (Direct) |
View |
| 2024-12-19 Option Award |
2024-12-20 4:16 pm |
N/A 2034-12-18 |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
1,111,029 | $0 | 2,048,635 (Direct) |
View |
| 2024-12-16 Tax Withholding |
2024-12-18 6:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
15,668 | $6.04 | 473,867 (Direct) |
View |
| 2024-12-17 Tax Withholding |
2024-12-18 6:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
7,057 | $6.95 | 473,867 (Direct) |
View |
Ownership |
2024-12-02 7:02 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Taylor Ben R Chief Financial Officer |
0 | $0 | 960,331 (Direct) |
View |
| 2020-05-07 Option Award |
2020-05-18 5:41 pm |
N/A 2030-05-06 |
TYME TECHNOLOGIES INC. | TYME | Taylor Ben R President, CFO |
1,860,000 | $0 | 1,860,000 (Direct) |
View |